Eden Research (LON:EDEN) Trading Down 13.2% – Here’s What Happened

Eden Research plc (LON:EDEN)’s stock price was down 13.2% on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares traded hands during mid-day trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Price Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market cap of £14.35 million, a P/E ratio of -9.42 and a beta of 0.92. The business’s fifty day moving average price is GBX 3.36 and its 200 day moving average price is GBX 3.71.

Insider Activity

In other news, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,952.94). Also, insider Sean M. Smith acquired 426,986 shares of the stock in a transaction on Tuesday, April 1st. The stock was bought at an average cost of GBX 234 ($3.03) per share, for a total transaction of £999,147.24 ($1,291,722.35). In the last three months, insiders have bought 1,391,473 shares of company stock valued at $103,604,725. 14.02% of the stock is currently owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.